Nivolumab With Epstein Barr Virus Specific T Cells (EBVSTS), Relapsed/Refractory EBV Positive Lymphoma (PREVALE)

NCT02973113 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

NonHodgkin Lymphoma
Lymphoproliferative Disorders
EBV Related Lymphoma
EBV-Related PTLD
Hodgkin Lymphoma
EBV Related Non-Hodgkin's Lymphoma
EBV Related Hodgkin's Lymphoma

Interventions

BIOLOGICAL: EBVST Cells
BIOLOGICAL: Nivolumab

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]